3
Announcements
Trials
Browse
Landscape
Status
Completed
62
Recruiting
19
Terminated
17
Active not recruiting
9
Withdrawn
5
Unknown
5
Not yet recruiting
3
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
7
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Head and Neck Neoplasms
11
Squamous Cell Carcinoma of Head and Neck
6
Thyroid Neoplasms
5
Thyroid Nodule
3
Thyroid Diseases
3
Parathyroid Neoplasms
3
Neoplasms
3
Epilepsy
3
Stress Disorders, Post-Traumatic
2
Parkinson Disease
2
Ovarian Neoplasms
2
Hyperthyroidism
2
Diabetes Mellitus
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Amyotrophic Lateral Sclerosis
2
von Willebrand Disease, Type 3
1
beta-Thalassemia
1
Xanthomatosis, Cerebrotendinous
1
X-Linked Combined Immunodeficiency Diseases
1
Wolman Disease
1
Waardenburg syndrome type 2A
1
Waardenburg syndrome type 2
1
Waardenburg Syndrome
1
Vitamin A Deficiency
1
VLCAD deficiency
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Usher syndrome, type 1F
1
Usher syndrome, type 1C
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Small Cell Lung Carcinoma
×
Head & Neck
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled